FrancophonIA/ELRC3.0 huggingface dataset:
English: Ciprofloxacin should generally not be used in patients with a history of tendon disease/disorder related to quinolone treatment.
Slovenian: Ciprofloksacin se praviloma ne sme uporabljati pri bolnikih z boleznimi/poškodbami kit v anamnezi, ki so bile povezane z zdravljenjem s kinoloni.
English: Do not take Ciprofloxacin Bayer if you are:
Slovenian: Ne jemljite zdravila Ciprofloksacin Bayer, če:
English: • Treatment of infections in neutropenic patients
Slovenian: • zdravljenje okužb pri nevtropeničnih bolnikih,
English: Petechiae Erythema multiforme Erythema nodosum StevensJohnson syndrome (potentially lifethreatening) Toxic epidermal necrolysis (potentially lifethreatening)
Slovenian: Erythema nodosum StevensJohnsonov sindrom (lahko smrtno nevaren) toksična epidermalna nekroliza (lahko smrtno nevarna)
English: Daily dose in mg Total duration of treatment (including switch to oral therapy as soon as possible)
Slovenian: Odrasli indikacije dnevni odmerki (mg) skupno trajanje zdravljenja (tudi peroralno zdravljenje takoj, ko je možno)
English: Tendinitis and tendon rupture (especially Achilles tendon), sometimes bilateral, may occur with ciprofloxacin, as soon as the first 48 hours of treatment.
Slovenian: Včasih se lahko po zdravljenju s ciprofloksacinom (v prvih 48 urah zdravljenja) pojavi tendinitis ali ruptura kite (predvsem Ahilove tetive), včasih obojestransko.
English: 5 - After completion of treatment, return all unused drugs to your chemist's shop to ensure they will be disposed of correctly.
Slovenian: Po končanem zdravljenju vrnite neuporabljeno zdravilo v lekarno.
English: Enterobacter aerogenes Enterobacter cloacae*
Slovenian: Enterobacter aerogenes Enterobacter cloacae * Escherichia coli *
English: Other severe infections in accordance with official guidance, or after careful benefit-risk evaluation when other treatments cannot be used, or after failure to conventional therapy and when the microbiological documentation can justify a ciprofloxacin use.
Slovenian: Za zdravljenje drugih hudih okužb je treba upoštevati veljavne smernice ali natančno oceniti razmerje tveganja in koristi, ko druga zdravljenja ne pridejo v poštev, ali ko je bilo običajno zdravljenje neuspešno in mikrobiološki izvidi opravičujejo uporabo ciprofloksacina.
English: Clozapine
Slovenian: Klozapin
English: • Prophylaxis of invasive infections due to Neisseria meningitidis
Slovenian: • preprečevanje invazivnih okužb, ki jih povzroča Neisseria meningitidis
English: other than Shigella dysenteriae type 1 and empirical treatment of severe travellers' diarrhoea
Slovenian: najmanj 14 dni driska, ki jo povzročajo bakterije, tudi iz vrste Shigella spp., ne pa Shigella dysenteriae tipa 1 in empirično zdravljenje hude potovalne driske
English: Cases of polyneuropathy (based on neurological symptoms such as pain, burning, sensory disturbances or muscle weakness, alone or in combination) have been reported in patients receiving ciprofloxacin.
Slovenian: Pri bolnikih, ki so prejemali ciprofloksacin, so poročali o polinevropatiji (na osnovi nevroloških simptomov, npr. bolečina, žarenje, senzorične motnje ali mišična oslabelost; bodisi posamezen simptom ali kombinacija simptomov).
English: • Inhalation anthrax (post-exposure prophylaxis and curative treatment) Ciprofloxacin may also be used to treat severe infections in children and adolescents when this is considered to be necessary.
Slovenian: − vranični prisad (izpostavljenost povzročitelju z vdihavanjem) Zdravilo Ciprofloksacin Bayer se lahko uporablja za zdravljenje hudih okužb pi otrocih in mladostnikih, kadar zdravnik presodi, da je to potrebno.
English: Clinical surveillance and appropriate adjustment of clozapine dosage during and shortly after coadministration with ciprofloxacin are advised (see section 4.4).
Slovenian: Priporoča se klinično spremljanje bolnika in ustrezna prilagoditev odmerkov klozapina med zdravljenjem in po koncu zdravljenju s ciprofloksacinom (glejte poglavje 4.4).
English: Aerobic Gram-negative micro-organisms Acinetobacter baumannii+
Slovenian: aerobni, po Gramu negativni mikroorganizmi Acinetobacter baumannii+
English: Ciprofloxacin Bayer should be administered by intravenous infusion.
Slovenian: Zdravilo Ciprofloksacin Bayer je treba infundirati intravensko.
English: Ciprobay Uro United Kingdom: Ciproxin
Slovenian: Ciprobay Uro Velika Britanija: Ciproxin
English: The in-vitro activity of ciprofloxacin against Mycobacterium tuberculosis might give false negative bacteriological test results in specimens from patients currently taking ciprofloxacin.
Slovenian: Pri bolnikih, ki jemljejo ciprofloksacin so lahko in vitro bakteriološki testi učinkovitosti ciprofloksacina proti Mycobacterium tuberculosis lažno negativni.
English: METHOD AND ROUTE(S) OF ADMINISTRATION For intravenous use
Slovenian: POSTOPEK IN POT(I) UPORABE ZDRAVILA intravenska uporaba
English: Daily dose in mg
Slovenian: indikacije dnevni odmerki (mg)
English: Haemolytic reactions have been reported with ciprofloxacin in patients with glucose-6-phosphate dehydrogenase deficiency.
Slovenian: Pri bolnikih s pomanjkanjem glukoza-6-fosfat dehidrogenaze, ki so prejemali ciprofloksacin, so poročali o hemolitičnih reakcijah.
English: Vasodilation Hypotension Syncope
Slovenian: Žilne bolezni vazodilatacija hipotenzija sinkopa vaskulitis
English: It must not be used if cloudy.
Slovenian: Če je raztopina motna, se je ne sme uporabiti.
English: PHARMACEUTICAL FORM Oral suspension (in single-dose sachets) [To be completed nationally]
Slovenian: FARMACEVTSKA OBLIKA peroralna suspenzija (vrečice za enkratno uporabo) [Izpolni država članica]
English: o Exacerbations of chronic obstructive pulmonary disease o Broncho-pulmonary infections in cystic fibrosis or in bronchiectasis o Pneumonia
Slovenian: o eksacerbacije kronične obstruktivne pljučne bolezni o okužbe bronhijev in pljuč pri cistični fibrozi ali bronhiektazi o pljučnica
English: Effects of other medicinal products on Ciprofloxacin:
Slovenian: Vpliv drugih zdravil na ciprofloksacin
English: 7 days
Slovenian: 7 dni zapleten pielonefritis
English: Aerobic Gram-positive micro-organisms Actinomyces Enteroccus faecium Listeria monocytogenes Aerobic Gram-negative micro-organisms Stenotrophomonas maltophilia Anaerobic micro-organisms Excepted as listed above Other micro-organisms Mycoplasma genitalium Ureaplasma urealitycum * Clinical efficacy has been demonstrated for susceptible isolates in approved clinical indications Resistance rate ≥ 50% in one or more EU countries ($): Natural intermediate susceptibility in the absence of acquired mechanism of resistance (1): Studies have been conducted in experimental animal infections due to inhalations of Bacillus anthracis spores; these studies reveal that antibiotics starting early after exposition avoid the occurrence of the disease if the treatment is made up to the decrease of the number of spores in the organism under the infective dose.
Slovenian: Propionibacterium acnes ODPORNI ORGANIZMI aerobni, po Gramu pozitivni mikroorganizmi Actinomyces Enteroccus faecium Listeria monocytogenes aerobni, po Gramu negativni mikroorganizmi Stenotrophomonas maltophilia anaerobni mikroorganizmi razen mikroorganizmov navedenih zgoraj drugi mikroorganizmi Mycoplasma genitalium Ureaplasma urealitycum * klinično učinkovitost so dokazali pri občutljivih izolatih za odobrene klinične indikacije + stopnja odpornosti ≥ 50 % v eni ali več državah Evropske unije ($) naravna vmesna občutljivost v odsotnosti pridobljene odpornosti (1): Študije so izvedli pri eksperimentalnih okužbah živali po inhalaciji spor Bacillus anthracis; te študije so odkrile, da antibiotiki dani čimprej po izpostavitvi, preprečijo pojav bolezni, če zdravljenje zmanjša število spor v organizmu po infektivnem odmerku.
English: Treatment of infections or prophylaxis of infections in neutropenic patients Ciprofloxacin should be coadministered with appropriate antibacterial agent(s) in accordance to official guidance.
Slovenian: največ 3 mesece zdravljenje okužb ali preprečevanje okužb pri bolnikih z nevtropenijo; ciprofloksacin je treba dati hkrati z ustreznim antibakterijskim zdravilom(i) v skladu z veljavnimi smernicami
English: The full spoon will give you a dose of 250 mg Ciprofloxacin Bayer.
Slovenian: Vsaka polna žlička vsebuje 250 mg ciprofloksacina.
English: No additions should be made to the mixed final ciprofloxacin suspension.
Slovenian: Pripravljeni suspenziji ciprofloksacina naj se ne dodaja nobenih dodatkov.
English: Oral suspension in single-dose sachets can be taken independent of mealtimes.
Slovenian: Peroralna suspenzija, vrečice za enkratno uporabo se vzame neodvisno od obrokov hrane.
English: Co-administration of probenecid and ciprofloxacin increases ciprofloxacin serum concentrations.
Slovenian: Sočasna uporaba probenecida in ciprofloksacin zveča serumsko koncentracijo ciprofloksacina.
English: film-coated tablets oral use
Slovenian: filmsko obložene tablete peroralna uporaba
English: The combination with other antibiotics, or its use as monotherapy could be considered adequate.
Slovenian: Ustrezna je tako samostojna uporaba (monoterapija) ali uporaba v kombinaciji z drugimi antibiotiki.
English: 124 to 168 250-500 mg every 12 h 250-500 mg every 24 h
Slovenian: glej običajno odmerjanje 124 do 168 250 - 500 mg vsakih 12 h 250 - 500 mg vsakih 24 h bolniki na hemodializi
English: • Broncho-pulmonary infections in cystic fibrosis caused by Pseudomonas aeruginosa
Slovenian: • akutno pljučno poslabšanje cistične fibroze, ki ga povzroča Pseudomonas aeruginosa
English: Ciprofloxacin Metabolites (M1-M4)
Slovenian: intravenska uporaba seč blato ciprofloksacin presnovki (M1 - M4)
English: From the data presented, ciprofloxacin prescriptions in “bone and joint infections” were supported by several clinical studies and an extensive use in clinical practice.
Slovenian: Predstavljeni podatki so z več kliničnimi študijami in obsežno uporabo v klinični praksi potrdili predpisovanje ciprofloksacina pri „okužbah kosti in sklepov“.
English: - broncho-pulmonary infections in cystic fibrosis or in bronchiectasis
Slovenian: - okužbe dihal pri cistični fibrozi ali bronhiektazijah
English: 124 to 168 200-400 mg every 12 h 200-400 mg every 24 h
Slovenian: glej običajno odmerjanje 124 do 168 200 - 400 mg vsakih 12 h 200 - 400 mg vsakih 24 h bolniki na hemodializi
English: 200-400 mg every 24 h (after dialysis)
Slovenian: 200 - 400 mg / 24 h (po dializi)
English: Marketing Authorisation Holder and Manufacturer [See Annex I - To be completed nationally] {Name and address} <{tel}> <{fax}> <{e-mail}>
Slovenian: Imetnik dovoljenja za promet z zdravilom in izdelovalec: [Glejte Dodatek I - Izpolni država članica] {Ime in naslov} <{tel}> <{fax}> <{e-mail}>
English: - allergic reaction, swelling (oedema), or rapid swelling of the skin and mucous membranes
Slovenian: − alergijska reakcija, otekanje (edem) ali hitro otekanje kože in sluznic (angioedem)
English: 6.6 Special precautions for disposal and other handling For ease of use the infusion vial stopper should be penetrated in the central ring.
Slovenian: 6.6 Posebni varnostni ukrepi za odstranjevanje in ravnanje z zdravilom Infundiranje je lažje, če se zamašek predre v sredini.
English: Bayer Vital GmbH D-51368 Leverkusen Germany
Slovenian: Bayer Vital GmbH D-51368 Leverkusen Nemčija
English: In summary, for prophylaxis in neutropenic patients, a 500 mg bid ciprofloxacin dosage regimen was recommended.
Slovenian: Za profilakso pri bolnikih z nevtropenijo je bil priporočen 500 mg odmerek ciprofloksacina z bid načinom odmerjanja.
English: Pancytopenia, Bone marrow depression, Anaphylactic shock, Psychotic reactions, Migraine, Olfactory nerve disorders, Hearing impaired, Vasculitis, Pancreatitis, Liver necrosis, Petechiae, Tendon rupture
Slovenian: Redki pancitopenija, depresija kostnega mozga, anafilaktični šok, psihotične reakcije, migrena, motnje vonja, okvara sluha, vaskulitis, pankreatitis, jetrna nekroza, petehije, pretrganje kite
English: • Ciprofloxacin Bayer may cause liver damage.
Slovenian: − Zdravilo Ciprofloksacin Bayer lahko povzoči jetrne okvare.
English: • Lower respiratory tract infections due to Gram-negative bacteria exacerbations of chronic obstructive pulmonary disease broncho-pulmonary infections in cystic fibrosis or in bronchiectasis pneumonia
Slovenian: • okužbe spodnjih dihal, ki jih povzročajo po Gramu negativne bakterije - eksacerbacije kronične obstruktivne pljučne bolezni - okužbe dihal pri cistični fibrozi ali bronhiektazijah - pljučnica
English: • Epididymo-orchitis, including cases due to Neisseria gonorrhoeae
Slovenian: • epididimo-orhitis, tudi če ga povzroča Neisseria gonorrhoeae
English: Daily dose in mg Total duration of treatment (potentially including initial parenteral treatment with ciprofloxacin)
Slovenian: indikacije dnevni odmerki (mg) skupno trajanje zdravljenja (lahko vključuje tudi začetno parenteralno zdravljenje s ciprofloksacinom)
English: • Lower respiratory tract infections due to Gram-negative bacteria:
Slovenian: • okužbe spodnjega dela dihalne poti z Gram negativnimi bakterijami:
English: 250-500 mg every 24 h (after dialysis)
Slovenian: 250 - 500 mg vsakih 24 h (po dializi)
English: Ciprofloxacin is largely excreted unchanged both renally and, to a smaller extent, faecally.
Slovenian: Ciprofloksacin se izloča večinoma nespremenjen skozi ledvice, preostanek pa z blatom.
English: dosage schedules duration of treatment
Slovenian: DATUM IZTEKA ROKA UPORABNOSTI ZDRAVILA
English: PHARMACOLOGICAL PROPERTIES 5.1 Pharmacodynamic properties Pharmacotherapeutic group: Fluoroquinolones, ATC code: J01MA02 Mechanism of action:
Slovenian: Farmakoterapevtska skupina: fluorokinoloni, oznaka ATC: J01MA02 Mehanizem delovanja
English: Complicated urinary tract infections and pyelonephritis Ciprofloxacin treatment of urinary tract infections should be considered when other treatments cannot be used, and should be based on the results of the microbiological documentation.
Slovenian: O možnosti zdravljenja okužb sečil s ciprofloksacinom je treba razmisliti kadar druga zdravljenja ne pridejo v poštev in na podlagi mikrobioloških izvidov.
English: Following oral administration of single doses of 250 mg, 500 mg, and 750 mg of ciprofloxacin tablets, ciprofloxacin is absorbed rapidly and extensively, mainly from the small intestine, reaching maximum serum concentrations 1-2 hours later.
Slovenian: Po peroralnem zaužitju se ciprofloksacin (tablete v odmerkih 250 mg/500 mg/750 mg) hitro in skoraj v celoti absorbira pretežno iz tankega črevesa.
English: Studies have been conducted in experimental animal infections due to inhalations of Bacillus anthracis spores; these studies reveal that antibiotics starting early after exposition, avoid the occurrence of the disease if the treatment is made up to the decrease of the number of spores in the organism under the infective dose.
Slovenian: te študije so odkrile, da antibiotiki dani čimprej po izpostavitvi, preprečijo pojav bolezni, če zdravljenje zmanjša število spor v organizmu po infektivnem odmerku.
English: If seizures occur Ciprofloxacin should be discontinued (see section 4.8).
Slovenian: Če se pojavijo krči, je treba zdravljenje s ciprofloksacinom prekiniti (glejte poglavje 4.8).
English: 400 mg twice daily to 400 mg three times a day
Slovenian: 400 mg dvakrat na dan do 400 mg trikrat na dan
English: COMMONLY SUSCEPTIBLE SPECIES Aerobic Gram-positive micro-organisms
Slovenian: SPLOŠNO OBČULJIVE VRSTE aerobni, po Gramu pozitivni mikroorganizmi
English: If you forget to take Ciprofloxacin Bayer
Slovenian: Če ste pozabili vzeti zdravilo Ciprofloksacin Bayer
English: Ciprofloxacin should not be taken with dairy products (e.g. milk, yoghurt) or mineral-fortified fruit juice (e.g. calcium-fortified orange juice) (see section 4.5).
Slovenian: Ciprofloksacin se ne sme jemati hkrati z mlečnimi izdelki (npr. mleko, jogurt) ali pijačami, obogatenimi z minerali (npr. s kalcijem obogaten pomarančni sok) (glejte poglavje 4.5).
English: Care should be taken to keep the affected limb at rest.
Slovenian: Prizadeta okončina naj miruje.
English: PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING HDPE BOTTLE 100 mg/mL
Slovenian: PODATKI NA PRIMARNI OVOJNINI HDPE PLASTENKA 100 mg/ml
English: In a clinical study with healthy subjects, there was an increase in serum tizanidine concentration (Cmax increase: 7-fold, range: 4 to 21-fold; AUC increase: 10-fold, range: 6 to 24-fold) when given concomitantly with ciprofloxacin.
Slovenian: V klinični študiji se je pri zdravih prostovoljcih, ki so sočasno s tizanidinom prejemali tudi ciprofloksacin zvečala serumska koncentracija tizanidina (zvišanje Cmax: 7-kratno, razpon: 4- do 21-kratno, zvišanje AUC:
English: Do not use Ciprofloxacin Bayer after the expiry date, which is stated on the carton after "EXP": The expiry date refers to the last day of the month concerned.
Slovenian: Zdravila Ciprofloksacin Bayer ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na ovojnini.
English: Ciprofloxacin Bayer may also be used to treat other specific severe infections in children and adolescents when your doctor considered this necessary.
Slovenian: Zdravilo Ciprofloksacin Bayer se lahko uporablja za zdravljenje hudih okužb pi otrocih in mladostnikih, kadar zdravnik presodi, da je to potrebno.
English: Two-month treatment duration in adults with oral ciprofloxacin given at the following dose, 500 mg bid, is considered as effective to prevent anthrax infection in humans.
Slovenian: Dvomesečno zdravljenje pri odraslih s peroralnim ciprofloksacinom z odmerkom 500 mg bid naj bi bilo prav tako učinkovito pri preprečevanju okužb z antraksom pri ljudeh.
English: Ciprofloxacin tablets should not be taken with dairy products (e.g. milk, yoghurt) or mineral-fortified fruit-juice (e.g. calcium-fortified orange juice) (see section 4.5).
Slovenian: Tablet ciprofloksacin se ne sme jemati hkrati z mlečnimi izdelki (npr. mleko, jogurt) ali pijačami, obogatenimi z minerali (npr. s kalcijem obogaten pomarančni sok) (glejte poglavje 4.5).
English: CIPROBAY 10 g/100 ml oral suspension oral use
Slovenian: CIPROBAY 10 g/100 ml peroralna suspenzija peroralna uporaba
English: INHERENTLY RESISTANT ORGANISMS
Slovenian: Mikroorganizmi občutljiva odporna
English: Use in humans is based on in-vitro susceptibility data and on animal experimental data together with limited human data.
Slovenian: Uporaba pri ljudeh je odvisna od in-vitro občutljivosti in podatkov pridobljenih iz preskušanj na živalih ter omejenih podatkov pridobljenih pri ljudeh.
English: • Lower respiratory tract infections due to Gram-negative bacteria
Slovenian: • okužbe spodnjih dihal, ki jih povzročajo po Gramu negativne bakterije
English: Visual disturbances
Slovenian: − motnje vida
English: Epididymo-orchitis and pelvic inflammatory diseases
Slovenian: okužbe spolovil epididimo-orhitis in medenična vnetna bolezen
English: CIPROBAY URO 100 mg film-coated tablets oral use
Slovenian: CIPROBAY URO 100 mg filmsko obložene tablete peroralna uporaba
English: Ciprofloxacin
Slovenian: ciprofloksacin
English: Protein binding of ciprofloxacin is low (20-30%).
Slovenian: Ciprofloksacin se slabo veže na plazemske beljakovine (20 - 30 %) in je v plazmi prisoten pretežno v neionizirani obliki.
English: • Infections of the bones and joints
Slovenian: • okužbe kosti in sklepov
English: At the first sign of any pain or inflammation stop taking Ciprofloxacin Bayer and rest the painful area.
Slovenian: Ob prvih znakih bolečine ali vnetja prekinite zdravljenje z zdravilom Ciprofloksacin Bayer.
English: Creatinine Clearance [mL/min/1.73 m²]
Slovenian: očistek kreatinina [ml/min/ 1,73m²]
English: Creatinine Clearance [mL/min/ 1.73 m²]
Slovenian: očistek kreatinina [ml/min/1,73m²]
English: • Broncho-pulmonary infections in cystic fibrosis caused by Pseudomonas aeruginosa.
Slovenian: • okužbe bronhijev in pljuč pri cistični fibrozi z Pseudomonas aeruginosa,
English: A 60-minute infusion of 400 mg ciprofloxacin every 8 hours is equivalent with respect to AUC to 750 mg oral regimen given every 12 hours.
Slovenian: AUC je po 60-minutnem infundiranju 400 mg ciprofloksacina na vsakih 8 ur enaka kot pri 750 mg peroralnem odmerku na vsakih 12 ur.
English: Complicated urinary tract infections and pyelonephritis
Slovenian: Zapletene okužbe sečil in pielonefritisa
English: Concurrent administration of ciprofloxacin and theophylline can cause an undesirable increase in serum theophylline concentration.
Slovenian: Sočasna uporaba ciprofloksacina in teofilina lahko zveča serumsko koncentracijo teofilina.
English: Children and adolescents Indication
Slovenian: Otroci in mladostniki indikacije dnevni odmerki (mg)
English: Ciprofloxacin should be administered by intravenous infusion.
Slovenian: Zdravilo ciprofloksacin je treba infundirati intravensko.
English: Plasmidmediated resistance encoded by qnr-genes has been reported.
Slovenian: Poročali so tudi o odpornosti, pridobljeni s plazmidi, ki imajo qnr gene.
English: Overall, the CHMP harmonised this section, providing particular attention to the available information on resistance to ciprofloxacin for each indication.
Slovenian: Povzetek glavnih značilnosti zdravila, poglavje 4.1: Terapevtske indikacije Odbor za zdravila za uporabo v humani medicini (CHMP) je v celoti uskladil to poglavje, pri čemer je posebno pozornost posvetil razpoložljivim podatkom o odpornosti na ciprofloksacin za vsako indikacijo.
English: Listeria monocytogenes Aerobic Gram-negative micro-organisms Stenotrophomonas maltophilia
Slovenian: Listeria monocytogenes aerobni, po Gramu negativni mikroorganizmi
English: Single-dose treatment of uncomplicated UTI:
Slovenian: Zdravljenje nezapletenih okužb sečil z enkratnim odmerkom:
English: The CHMP asked the applicant/MAH to discuss the extent to which ciprofloxacin could be viewed as an acceptable option in the treatment or prophylaxis in patients with severe neutropenia.
Slovenian: Zdravljenje ali profilaksa pri bolnikih s hudo nevtropenijo CHMP je predlagatelja/imetnika dovoljenja za promet z zdravilom zaprosil za pojasnitev, v kolikšni meri je zdravljenje s ciprofloksacinom sprejemljiva možnost zdravljenja ali profilaksa pri bolnikih s hudo nevtropenijo.
English: If you have any more questions about the use of this product, ask your doctor or pharmacist.
Slovenian: Če imate dodatna vprašanja o uporabi zdravila Ciprofloksacin Bayer, se posvetujte z zdravnikom ali farmacevtom.
English: Anaerobic micro-organisms
Slovenian: Yersinia pestis anaerobni mikroorganizmi
English: Anaphylactic reaction Anaphylactic shock (lifethreatening) (see section 4.4) Serum sicknesslike reaction
Slovenian: Bolezni imunskega sistema alergijska reakcija alergijski edem/angioedem anafilaktična reakcija anafilaktični šok (smrtno nevaren) (glejte poglavje 4.4) reakcija, podobna serumski
English: Important information about some of the ingredients of Ciprofloxacin Bayer Glucose [To be completed nationally]
Slovenian: Pomembne informacije o nekaterih sestavinah zdravila Ciprofloksacin Bayer Glukoza [Izpolni država članica]
English: Renal failure Haematuria Crystalluria (see section 4.4) Tubulointerstitial nephritis
Slovenian: okvara hematurija kristalurija (glejte poglavje tubulointersticijs ki nefritis
English: Broncho-pulmonary infections in cystic fibrosis
Slovenian: Okužbe dihal pri cistični fibrozi
English: Your doctor will explain to you exactly how much Ciprofloxacin Bayer you will have to take as well as how often and for how long.
Slovenian: Pri jemanju zdravila Ciprofloksacin Bayer natančno upoštevajte zdravnikova navodila, kdaj in kako pogosto morate vzeti peroralno suspenzijo in koliko časa jo morate jemati.
English: PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING HDPE BOTTLE 50 mg/mL
Slovenian: PODATKI NA PRIMARNI OVOJNINI HDPE PLASTENKA 50 mg/ml
English: How to store Ciprofloxacin Bayer Further information
Slovenian: Shranjevanje zdravila Ciprofloksacin Bayer Dodatne informacije
English: The active substance is ciprofloxacin.
Slovenian: Zdravilna učinkovina je ciprofloksacin.
English: • pentoxifylline (for circulatory disorders)
Slovenian: − pentoksifilina (za zdravljenje motenj obtočil)